Rick Lowe is a Principal Scientist specializing in potency at Pfizer since 2024, while also serving as a Senior Scientist in Potency Assay at Seagen. Previously, Rick held the role of Senior Manager in Analytical Development and Quality Control at Aptevo Therapeutics Inc from 2004 to 2021, through its transitions from Trubion to Emergent. Rick earned a Bachelor of Arts in a dual program of Cell/Cellular and Molecular Biology and Environmental Biology from the University of Colorado at Boulder, where they studied from 1987 to 1992.
This person is not in the org chart
This person is not in any teams
This person is not in any offices